IAM
The Long Read
Life sciences companies are frequently on the front line when it comes to being flexible on IP and pricing, says Ben Bourke of Womble Bond Dickinson. The most recent example of this is Moderna Therapeutics’ promise not to enforce patents relating to its approved covid-19 vaccine. Such a response makes sense and should be favoured over government-led initiatives to circumvent IP rights. Read more here
MONDAY 5th April
A look at Chinese companies’ semiconductor patent holdings suggests that their best bet for gaining globally relevant IP in the space is to acquire it. However, that leaves them with a big problem. Read more here
IAM
The Long Read
There is growing evidence that patent litigants are turning to
ex parte reexaminations to bolster their PTAB strategies. Cozen O’Connor’s Jeffrey Townes and Hongling Zou analyse why older USPTO tools deserve a second look and explore how to get best value from them. Read more here
MONDAY 29th March
Semiconductor Energy Laboratory, an R&D-based Japanese business, has expanded its first patent assertion campaign in nearly a decade with a lawsuit targeting TCL’s display affiliate. Read more here
Acacia CEO points to recent “astounding IP settlements and judgments” as signs that the patent market is rebounding. Read more here
Intel hit by $2bn WDTX damages; Top German court clamps down on holdout; Covid patent doubts; Nokia and Samsung video deal; China blockchain IP lead; and much more iam-media.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iam-media.com Daily Mail and Mail on Sunday newspapers.